Cell and gene therapy CRO market Share, Growth Analysis by 2035

It is worth mentioning that the presence of CROs has enabled small and mid-sized companies, which lack the necessary expertise and elaborate resources, to successfully initiate RD programs in several domains.

The financial opportunity within the Cell and Gene Therapy CROs Market has been analyzed across the following segments:

Area of Expertise
Cell Therapy
Gene Therapy

Scale of Operation
Preclinical
Clinical
Drug Discovery

Therapeutic Area
Oncological Disorders
Neurological Disorders
Cardiovascular Disorders
Infectious Diseases
Metabolic Disorders
Autoimmune Disorders
Blood Disorders
Rare / Genetic Disorders
Ophthalmic Disorders
Other disorders

Analysis by Geographical Regions
North America
Europe
Asia Pacific
Latin America
Middle East and North Africa

The Cell and Gene Therapy CROs Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:

Altasciences
Charles River Laboratories
Creative Biolabs
IQVIA
Medpace
PPD
Precision for Medicine
Accelera
Evotec
ICON
Syneos Health
CMIC Group
Labcorp

Table of Contents

Preface
Executive Summary

Introduction

Guide To Outsourcing

Market Landscape

Company Profiles

Competitive Benchmarking

Partnerships And Collaborations

Mergers and Acquisitions

Key Acquisition Targets

Likely Partner Analysis for Cell Therapy CROs

Likely Partner Analysis for Gene Therapy CROs

Clinical Trial Analysis

Total Cost of Ownership for Cell and Gene Therapy Contract Research Organizations

Market Forecast and Opportunity Analysis

Swot Analysis

Conclusion

Interview And Survey Transcripts

Appendix 1: Tabulated Data

Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link:

https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html

You may also be interested in the following titles:

Women’s Digital Health Market

Modular Manufacturing Facilities Market

You may also like to learn what our experts are sharing in Roots educational series:

Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market?

Artificial Intelligence (AI) In Oncology: Current Scenario And Future Potential

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415
Ben.johnson@rootsanalysis.com